Washington University School of Medicine

Digital Commons@Becker
Psychiatry Faculty Publications

Department of Psychiatry

2014

Progress in research on Tourette syndrome
Kevin J. Black
Washington University School of Medicine in St. Louis

Joseph Jankovic
Baylor College of Medicine

Tamara Hershey
Washington University School of Medicine in St. Louis

Kevin St. P McNaught
Tourrette Syndrome Association

Jonathan W. Mink
University of Rochester

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/psych_facpubs

Recommended Citation
Black, Kevin J.; Jankovic, Joseph; Hershey, Tamara; McNaught, Kevin St. P; Mink, Jonathan W.; and
Walkup, John, "Progress in research on Tourette syndrome" (2014). Psychiatry Faculty Publications. Paper
6.
https://digitalcommons.wustl.edu/psych_facpubs/6

This Article is brought to you for free and open access by the Department of Psychiatry at Digital
Commons@Becker. It has been accepted for inclusion in Psychiatry Faculty Publications by an authorized
administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

Authors
Kevin J. Black, Joseph Jankovic, Tamara Hershey, Kevin St. P McNaught, Jonathan W. Mink, and John
Walkup

This article is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/psych_facpubs/6

Author's Accepted Manuscript

Progress in research on Tourette syndrome
Kevin J. Black, Joseph Jankovic, Tamara Hershey, Kevin St. P. McNaught, Jonathan W. Mink,
John Walkup

www.elsevier.com/locate/jocrd

PII:
DOI:
Reference:

S2211-3649(14)00022-0
http://dx.doi.org/10.1016/j.jocrd.2014.03.005
JOCRD146

To appear in:

Journal of Obsessive-Compulsive and Related Disorders

Received date: 28 February 2014
Accepted date: 12 March 2014
Cite this article as: Kevin J. Black, Joseph Jankovic, Tamara Hershey, Kevin St. P.
McNaught, Jonathan W. Mink, John Walkup, Progress in research on Tourette
syndrome, Journal of Obsessive-Compulsive and Related Disorders, http://dx.doi.org/
10.1016/j.jocrd.2014.03.005
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal
pertain.

Progress in research on Tourette syndrome

Kevin J. Black, M.D. (1) *
Joseph Jankovic, M.D. (2)
Tamara Hershey, Ph.D. (3)
Kevin St. P. McNaught, Ph.D. (4)
Jonathan W. Mink, M.D., Ph.D. (5)
John Walkup, M.D. (6)

(1) Departments of Psychiatry, Neurology, Radiology, and Anatomy & Neurobiology, Washington
University School of Medicine, St. Louis, MO
(2) Department of Neurology, Baylor College of Medicine, Houston, Texas
(3) Departments of Psychiatry, Neurology, and Radiology, Washington University School of
Medicine, and Department of Psychology, Washington University, St. Louis, MO
(4) Tourette Syndrome Association, Bayside, NY
(5) Departments of Neurology, Neurobiology and Anatomy, Brain and Cognitive Sciences, and
Pediatrics, University of Rochester, Rochester, NY
(6) Division of Child and Adolescent Psychiatry, Department of Psychiatry, Weill Cornell Medical
College and New York‐Presbyterian Hospital, New York, NY

*Direct questions to this author, at kevin@WUSTL.edu

Progress in research on Tourette syndrome

ABSTRACT

Tourette syndrome (TS) is a heritable neuropsychiatric disorder commonly complicated by obsessions
and compulsions, but defined by frequent unwanted movements (motor tics) and vocalizations (phonic
tics) that develop in childhood or adolescence. In recent years, research on TS has progressed rapidly on
several fronts. Inspired by the Fifth International Scientific Symposium on Tourette Syndrome, the
articles in this special issue review advances in the phenomenology, epidemiology, genetics,
pathophysiology, and treatment of TS.

INTRODUCTION

Tourette syndrome (TS) is defined by chronic, but variable, unwanted movements (motor tics) and
sounds (phonic tics) that develop spontaneously in childhood or adolescence. However, this relatively
simple definition neither conveys the breadth of clinical symptoms and disability that TS can produce in
patients nor explains the fascination TS has evoked in physicians, scientists, and the general public.

Research on TS has grown increasingly rapidly over the past several decades (see Figure 1). The Tourette
Syndrome Association, which provided much of the preliminary funding for these initiatives, has helped
disseminate research advances by hosting five International Scientific Symposia on Tourette Syndrome.
The most recent such symposium took place on June 12‐13, 2009, in New York City. Over 250 experts
and delegates from 17 countries attended the meeting, which included 24 plenary lectures, 7 round
table discussions and 57 poster presentations.

Several notable studies were presented for the first time at the Fifth Symposium. To give only two
examples, Dr. Larry Scahill discussed results of a very large study of the prevalence of medically
diagnosed Tourette syndrome in the United States, published only a few days earlier by the U.S. Centers
for Disease Control and Prevention (CDC).1 Dr. Doug Woods reported for the first time the results of one
of the largest randomized controlled trials of any treatment for tics, which tested the efficacy of a
behavioral treatment for tics called CBIT (Comprehensive Behavioral Intervention for Tics); the results
generated substantial enthusiasm and discussion and were subsequently published in JAMA.2 Abstracts
and video clips from plenary lectures are available online (http://www.tsa‐
usa.org/Z_IntSciSymp5/IntlSciSymposTS5_contents.html), as are poster abstracts (http://www.tsa‐
usa.org/aResearch/images/5thIntlSciSympPosterAbstracts.pdf).

This introductory article will point out highlights of the work presented at the Symposium and introduce
the remaining articles, in which speakers from the Symposium provide updated summaries of research
in their respective areas of TS expertise. Together, the articles in this special issue comprise a solid
introduction to the current state of research on TS. Dr. Andrea Cavanna first discusses the
phenomenological, genetic and other features that link TS and obsessive‐compulsive disorder,3 followed
by a review of the phenomenology of tic disorders by Dr. James Leckman and colleagues.4

TS RESEARCH HIGHLIGHTS

The known heritability of TS provides tantalizing potential for progress in understanding its causes and
pathophysiology. At the Symposium, Dr. Nelson Freimer reviewed the current state of genetics research
in TS, including results from multisite collaborative studies of sib pairs and large multigenerational
families, which together involved DNA from over 2,000 individuals.5 A locus on the short arm of

chromosome 2 was most robustly linked to susceptibility to TS. Genome‐wide association studies were
being analyzed, with preliminary evidence for several strong signals that were being followed up for
specificity. Combined studies with OCD symptoms in TS probands and vice versa were promising leads.
Some of the studies discussed have published results since the meeting.6‐8 Dr. Jim Hudziak reported on a
genetic study of a large sample of children (30,000+). This study showed strong evidence for high
heritability of tics (explaining 69‐78% of the variance), with environmental effects limited to those
unique to each individual rather than those environmental effects shared by family members. In this
issue, Dr. David Pauls and colleagues update the status of the search for the genes responsible for the
high heritability of TS.9, 10

Other presentations focused on the physiology of tic disorders, a topic reviewed comprehensively
elesewhere.11‐16 Dr. Suzanne Haber discussed research on the anatomy of the basal ganglia, focusing on
how the organization of its connections with the cortex of the brain may underlie the development of
both normal and abnormal movements. Dr. Flora Vaccarino discussed her exciting research findings on
the substantial (~50%) loss of certain interneurons in the striatum in postmortem brain samples from
people who had TS during life. Dr. Joshua Berke discussed his research into the function of these
interneurons and their response to behavioral tasks and drugs that affect dopaminergic
neurotransmission. Dr. Bradley Schlaggar discussed important results from his laboratory’s brain
imaging studies in TS, which show a difference in TS in the patterns of simultaneous, spontaneous
fluctuations in the activity of different regions of the brain (functional connectivity). Drs. Jessica Church
and Schlaggar place that work in context of other neuroimaging findings in a report in this issue17, see also 18
Presentations by Drs. Barak Caine and Joseph Garner discussed potential translational science
approaches using animal models to understand the cause and physiology of tics or to rapidly screen
potential new treatments.

Another Symposium session focused on public health and the connections between science, patients
and the public. Dr. Larry Scahill presented data from the CDC epidemiological study mentioned above;1
for this issue, he and his colleagues summarize recent studies on the prevalence of TS.19 Dr. John Walkup
reported on information on “real‐life” TS treatment from two large samples, one from Medicaid and one
from private insurers.8 The results suggest that many children with tics do not get medical attention, and
that those who do present to clinicians have substantial comorbidity. Dr. Anne‐Liis von Knorring
reported on comorbid symptoms in tic patients from community samples. In clinical samples, biases
were suspected to have inflated the rate of comorbid psychological symptoms. However, even in her
community samples of TS or chronic motor/vocal tic disorder, almost all children (92%) had at least one
psychiatric diagnosis in addition to the chronic tic disorder. Dr. Doug Woods presented results of a
survey of 741 adults with tics or parents of children with tic disorders. The survey revealed that
treatment actually being received does not reflect current standards of care. For instance, haloperidol
was the most common treatment for adults, and although habit reversal (HRT) or CBIT is well proven to
be effective, almost no patients had been treated with it; in fact, in terms of number of patients treated,
HRT/CBIT came in 6th place, after 5 unproven psychotherapies including relaxation. This finding probably
reflects in part a need to better inform physicians of the treatment’s efficacy, but other possible
explanations include a shortage of trained HRT/CBIT therapists and the fact that clinical trials
participants do not represent the full range of patients seen in clinical settings (e.g. research studies
require a patient and parent who can comply with the treatment protocol).

A session on neuroimmunology provoked vigorous debate. Speakers included Drs. Tanya Murphy,
Michael Schwartz, Gavin Giovannoni, Roger Kurlan, and James Leckman. Although new data continue to
raise interesting questions about the association of psychological stress, infections with Group A
streptococci or other pathogens, immune markers, and current symptom status, substantial
disagreement remained after the session on several key issues. Chief among these were questions about

the direction of causality of these associations, their specificity, and whether any direct causative
relationship between infectious response and symptoms pertained to few or many patients with TS.

One attempt to address the controversy surrounding pediatric autoimmune neuropsychiatric disorders
associated with streptococcal infections (PANDAS) has been the proposal of a new entity, termed
Pediatric Acute‐onset Neuropsychiatric Syndrome (PANS).20 In contrast to PANDAS, the diagnostic
criteria for PANS reduce the focus on tics by requiring “abrupt, dramatic onset of obsessive‐compulsive
disorder or severely restricted food intake” rather than “presence of [OCD] or a tic disorder,” and by
excluding patients whose symptoms are “better explained by … Tourette disorder.” However, tics are
retained in the PANS criteria as one of several “additional neuropsychiatric symptoms, with similarly
severe and acute onset,”20 and the validity and utility of this new proposed diagnosis will continue to be
studied.

The first step in the management of patients with TS is proper education of the patient, family
members, teachers, and other individuals who frequently interact with the patient about TS. They
should be encouraged to work together to provide the best therapeutic approach and implement
behavioral, pharmacological, and, if necessary, surgical therapy to target the most troublesome
symptoms. While the selection of the treatment option should be evidence‐based, each individual is
different and, therefore, the treatment must be tailored specifically to the needs of the individual
patient and may also be influenced by the personal preference and experience of the treating
physician.16 At the Symposium, Dr. Veerle Visser‐Vanderwalle reviewed deep brain stimulation (DBS) for
tics, a treatment that may be appropriate for certain very carefully selected patients.21 The Tourette
Syndrome Association has sponsored the creation of an international database for DBS in TS
(http://dbs.tsa‐usa.org/). DBS also may provide insights into brain regions that may affect tic severity.14,

22

Similar insights were offered in a review of pharmacological treatments for TS by Drs. Donald Gilbert

and Joseph Jankovic. Articles in this issue update both presentations.23, 24

Finally, the Fifth Symposium for the first time devoted a session to behavior therapy of tics. Dr. Adam
Aron discussed research into how the brain manages the volitional control of movement. Dr. Alan
Peterson discussed misunderstandings of behavior therapy as applied to TS. Specifically, he clarified that
modern behavior therapists understand that TS is caused largely by one’s genes, but that manipulations
of the environment affect momentary and situational tic severity. “Behavior therapy for tics is not a
cure, but a management strategy that can help people live a better life.” He also summarized research
debunking myths that HRT/CBIT would lead to rebound worsening of tics or to substitution of new tics
for those targeted in treatment. Dr. Cara Verdellen described her research and clinical experience with
exposure and response prevention (E/RP) as an alternative behavioral therapy for tics, inspired by its
success in OCD. Finally, Drs. Doug Woods and John Piacentini reported and discussed the results of the
multi‐site randomized controlled trial (RCT) of CBIT versus a nonspecific psychological therapy in 126
children with TS.2 An RCT of CBIT in adults with TS, using the same study design and a similar sample
size, has since been completed.25 Each of these CBIT studies is among the largest RCTs ever conducted
for TS.26

A LOOK FORWARD

In the Fifth Symposium’s opening session, Dr. John Walkup provided a provocative discussion of the
novel implications of the results of the CBIT trial. He pointed out that these results might lead to several
paradigm changes in how patients, family members, and treating clinicians think about TS and its
treatment (see http://www.tsa‐usa.org/Z_IntSciSymp5/Session1/VideoPlayer.html; compare Figure 2).

Dr. Walkup acknowledged that recognizing the efficacy of behavioral strategies for tics can cause
uncomfortable paradigm shifts for some, or misunderstandings by others, but he highlighted how this
recognition can also empower patients and families.

Time will tell how prescient or premature these predictions prove to be, but one hopes that they point
in the general direction of an appropriate correction to how TS is viewed by patients, physicians and the
general public. In the 1970s and 1980s, the discovery that medications could substantially improve TS
symptoms led to one of the defining missions of the nascent Tourette Syndrome Association: a vigorous
defense against the then‐prevalent (but empirically unsupported) view that tics resulted from
psychologically immature responses to sexual drives or noxious early‐life experiences, and should be
treated by insight‐oriented psychotherapy. The TSA’s focus on biological therapy was widely adopted by
physicians into the first decade of the new millennium; it helped many patients find appropriate
treatment, reduced societal stigma, and helped drive important research. However, this focus also
fostered over‐corrections at times, such as assertions by some writers that “[all] psychotherapy is
useless” for tics, or implications that only neurologists should manage TS. With these writers, the
pendulum had swung a little too far. After all, tics are influenced by social context, they differ from
other abnormal movements in part by suppressibility and a perception of volitional control,16, 27 and for
many TS patients tics are not the most troubling symptom.28

Fortunately this tunnel vision was not universal; for instance, the TSA funded some of the earliest
rigorous research on behavior therapy for tic treatment, encouraged continued research on non‐tic
manifestations of TS, and provided crucial support for the Behavioral Science Consortium’s creation and
the recent CBIT efficacy trials. The TSA has also recognized that expertise in TS extends beyond guild
boundaries: the organization’s Medical Advisory Board has predominantly been staffed by neurologists
and psychiatrists, but psychology, nursing, and other fields have also contributed. The editors of the

Fourth Symposium’s report rejected a suggestion that TS should be reclassified as a purely neurological
disorder, in favor of a more balanced view: “At the moment, the placement of TS in the psychiatric
sphere of nosology seems stable, although debatable; in the future, we hope there will be a new
perspective that will eliminate the need for such an either‐or designation.”29

The developments in TS research reviewed in the following articles only strengthen this view. Hopefully
the upcoming Sixth International Symposium on Tourette Syndrome will report not only breakthroughs
in research but also wider acceptance of a balanced, empirically based view of TS. Such acceptance
would include openness to evidence‐based treatments whether psychological, pharmacological or
surgical, an approach that will continue to invite collaboration of clinicians and researchers from diverse
fields of expertise.
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TABLE 1. Paradigm shift in TS treatment suggested by the success of CBIT (table from John C. Piacentini,
Ph.D.)

Old paradigm
Ignore your tics
Tics can’t be controlled
Don’t punish
Don’t try to suppress tics
Tics and urges to tic get worse when you suppress
Suppressing one tic makes new tics develop

New paradigm
Become more aware of your tics
Learn to manage tics
Reward efforts to manage tics
Use behavioral strategies
Tics and urges improve with behavioral treatment
New tics don’t develop from behavioral treatment
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Research Highlights
•
•
•
•
•

Tourette syndrome and OCD overlap partially in terms of genetics and phenomenology
Articles in this special issue review recent advances in Tourette syndrome research
This article summarizes presentations at the Fifth International Symposium on TS
Advances have occurred in epidemiology, genetics, physiology and treatment of TS
Behavior therapy for tics is effective, but not yet widely adopted in patient care

